ARCHIVES

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Sets its Targets for Grant Success Rate and R01 Payline for FY05.

January 21, 2005

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer

May 16, 1986

NCI Plans Conference To Reconsider Breast Cancer Screening In women 40-49

April 19, 1996

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011

DCT Board Gives Concept Approval to Recompetition Of In Vitro Assay For New Drug Screening Program

February 24, 1984